ArticleCancer chemotherapy and pharmacology2013

Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas.

Shivaani Kummar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.